AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
203.10
+2.22 (1.11%)
Feb 21, 2025, 3:22 PM EST - Market open
AbbVie Revenue
In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth. AbbVie had revenue of $15.10B in the quarter ending December 31, 2024, with 5.60% growth.
Revenue (ttm)
$56.33B
Revenue Growth
+3.71%
P/S Ratio
6.31
Revenue / Employee
$1,024,255
Employees
55,000
Market Cap
358.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
Abbott Laboratories | 41.95B |
ABBV News
- 1 day ago - How Dividend Investing Helps Parents Fund College Education Fees - Seeking Alpha
- 2 days ago - AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer Healthcare Giant - Seeking Alpha
- 2 days ago - My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys - Seeking Alpha
- 2 days ago - Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital - Business Wire
- 2 days ago - AbbVie Appears Ready To Move Higher - Seeking Alpha
- 7 days ago - AbbVie: An Undervalued Dividend Aristocrat - Seeking Alpha
- 7 days ago - AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors - PRNewsWire
- 7 days ago - All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On - Seeking Alpha